Wellstar International, Inc. (WLSI) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerWellstar International, Inc. (WLSI) trades at $0.00001. Wellstar International, Inc. is a development-stage company previously focused on thermal imaging technology for healthcare applications. Currently, the company does not have significant operations. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for WLSI: WLSI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Wellstar International, Inc. (WLSI) Healthcare & Pipeline Overview
Wellstar International, Inc., formerly involved in developing thermal imaging technology for early breast cancer detection and other medical applications, currently lacks significant operations and faces challenges in a competitive medical device market, reflected in its limited market capitalization and negative beta.
What Is the Investment Thesis for WLSI?
Investing in Wellstar International, Inc. presents significant risks due to its current lack of significant operations and limited market capitalization of $0.00B. The company's negative P/E ratio of -0.00 reflects its lack of profitability. The negative beta of -5.79 suggests an inverse correlation with the market, potentially due to its distressed state. Any investment would rely on a successful turnaround strategy, potentially involving new management, a revised business plan, or the acquisition of promising assets. However, the absence of current revenue generation and the lack of publicly available information make it difficult to assess the company's potential for future growth or profitability. Investors should carefully consider the high level of uncertainty and the potential for complete loss of investment.
Based on FMP financials and quantitative analysis
WLSI Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited investor interest.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Negative beta of -5.79 suggests an inverse correlation with the market, potentially due to its distressed state.
- The company currently has no dividend yield, reflecting its lack of profitability and cash flow.
- The company's employee count is 4, indicating a very small operation.
Who Are WLSI's Competitors?
WLSI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ABT Abbott Laboratories | $97.50 | +0.84% | $169B | — |
| MDT Medtronic plc | $86.38 | -0.07% | $111B | — |
| SYK Stryker Corporation | $283.35 | +2.88% | $109B | — |
| BSX Boston Scientific Corporation | $42.60 | -1.46% | $63.3B | — |
| EW Edwards Lifesciences Corporation | $85.15 | -0.05% | $49.0B | — |
| DXCM DexCom, Inc. | $85.36 | -1.01% | $32.2B | — |
| PHG Koninklijke Philips N.V. | $23.92 | +0.46% | $23.4B | — |
| STE STERIS plc | $208.54 | -0.38% | $20.3B | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WLSI's Key Strengths?
Potentially valuable intellectual property related to thermal imaging.
- Experienced management team (though small).
- Established presence in Holland, Ohio.
- Previous focus on a niche market with potential for growth.
What Are WLSI's Weaknesses?
Lack of significant operations.
- Limited financial resources.
- Small employee base.
- Dependence on a single technology (thermal imaging).
What Are the Key Risks for WLSI?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited financial resources and lack of significant operations.
- Intense competition in the medical device industry.
- Rapid technological advancements rendering existing technology obsolete.
- Stringent regulatory requirements.
- Economic downturn impacting healthcare spending.
What Are WLSI's Competitive Advantages?
- Potentially held intellectual property related to its thermal imaging technology.
- May have had established relationships with key opinion leaders in the medical field.
- First-mover advantage in specific niche applications of thermal imaging.
What Does WLSI Do?
Wellstar International, Inc., founded in 1997 and based in Holland, Ohio, was once engaged in the development and licensing of advanced thermal imaging technology through its subsidiary, Trillennium Medical Imaging, Inc. The company's focus was on consumer healthcare markets, with its technology aimed at providing diagnostic screening for early breast cancer detection, differential diagnosis of pain dysfunctions like reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders. Additionally, their technology was intended for the detection of pressure ulcers, deep tissue injuries, bed sores, and orthopedic applications. However, Wellstar International, Inc. currently does not have significant operations. The company's transition from active development and licensing to a state of limited operations raises questions about its future direction and potential for revitalization within the medical device industry. The company's past focus on thermal imaging placed it in a niche segment of the medical device market, competing with companies offering alternative diagnostic and monitoring solutions. The absence of current operations suggests challenges in commercializing its technology or adapting to evolving market demands.
What Products and Services Does WLSI Offer?
- Formerly developed thermal imaging technology for medical applications.
- Aimed to provide diagnostic screening for early breast cancer detection.
- Sought to aid in the differential diagnosis of pain dysfunctions.
- Intended to assist in the detection of pressure ulcers and deep tissue injuries.
- Explored orthopedic applications for its thermal imaging technology.
- Currently does not have significant operations.
How Does WLSI Make Money?
- Previously focused on developing and licensing thermal imaging technology.
- Aimed to generate revenue through licensing agreements with medical device manufacturers.
- Potentially sought to generate revenue through direct sales of thermal imaging devices.
What Industry Does WLSI Operate In?
Wellstar International, Inc. previously operated within the medical device industry, specifically targeting the thermal imaging segment. This market is characterized by rapid technological advancements, stringent regulatory requirements, and intense competition. Companies in this sector must continuously innovate and adapt to evolving healthcare needs to maintain a competitive edge. The absence of current operations for Wellstar International, Inc. places it at a significant disadvantage compared to established players with ongoing research and development, manufacturing, and distribution capabilities. Competitors like CNTRF and CSUI are actively engaged in the medical device market.
Who Are WLSI's Key Customers?
- Potentially targeted hospitals and clinics for diagnostic screening applications.
- May have targeted physicians specializing in pain management and orthopedics.
- Could have targeted consumers for early breast cancer detection.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
Wellstar International, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for Wellstar International, Inc. stands at 5.7%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Wellstar International, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Holland, US. The company is led by CEO John Antonio. WLSI has traded publicly since 2006.
WLSI Financials
WLSI Latest News
No recent news available for WLSI.
WLSI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for WLSI.
Price Targets
Wall Street price target analysis for WLSI.
WLSI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for WLSI; grades run from A+ (80-100) to F (below 30).
Leadership: John Antonio
Managing
John Antonio is currently managing Wellstar International, Inc. with a team of 4 employees. His role involves overseeing the company's operations and strategic direction, though the company currently lacks significant operations.
Track Record: Due to the company's current lack of significant operations, it is difficult to assess John Antonio's track record. His leadership will be crucial in any potential turnaround or revitalization efforts. However, there is no publicly available information regarding specific achievements or milestones under his leadership.
WLSI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Wellstar International, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may be subject to limited regulatory oversight and may not be required to file regular financial reports with the SEC. This lack of transparency can increase the risk for investors, as it may be difficult to obtain reliable information about the company's financial performance and operations. Investing in companies on the OTC Other tier requires a high degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Limited regulatory oversight and disclosure requirements.
- Low liquidity and wide bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of financial distress or bankruptcy.
- Difficulty in obtaining reliable information about the company.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Determine if the company has an attorney of record.
- Company has been in existence since 1997.
- Company has a registered address and contact information.
- Company has a CEO/Managing person.
- Company operates in the Healthcare sector.
What Investors Ask About Wellstar International, Inc. (WLSI) — Healthcare
What do analysts say about WLSI stock?
There is currently no analyst coverage available for Wellstar International, Inc. due to its limited market capitalization and lack of significant operations. The company's financial performance is not tracked by major financial data providers, and there is no consensus view on its future prospects. Investors should conduct their own thorough research and due diligence before considering an investment in WLSI.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's lack of significant operations and limited public disclosures.